FDAnews
www.fdanews.com/articles/186875-stimguard-approved-for-sacral-nerve-stimulator
Purple_Approved_Stamp.gif

StimGuard Approved for Sacral Nerve Stimulator

May 18, 2018

StimGuard’s wireless neuromodulation device received a CE Mark for treating chronic, persistent symptoms of overactive bladder.

The device injects a therapy using a needle and can be configured using an Apple iPad for advanced programming. It eliminates the need for implantation of a battery source in the patient, which requires surgery.

The nerve stimulator places a small device equipped with electrode contacts and an embedded chip in the patient’s body through a needle paired with a wire receiver.

View today's stories